Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.

• Risk models to predict prostate cancer on biopsy, whether they include only prostate-specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening history.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Aged

Biopsy

Early Detection of Cancer

Forecasting

Humans

Kallikreins

analysis

Male

Middle Aged

Models

Statistical

Prostate-Specific Antigen

analysis

Prostatic Neoplasms

diagnosis

Randomized Controlled Trials as Topic

Tumor Markers

Biological

analysis

prostate specific antigen

prostate cancer

screening

kallikreins

molecular markers

Publication and Content Type

ref (subject category)

art (subject category)